In vitro and in vivo antimicrobial efficacy of natural plant-derived compounds against Vibrio cholerae of O1 El Tor Inaba serotype

Author:

Kim Hyung-Ip1,Kim Ji-Ae1,Choi Eun-Jin2,Harris Jason B34,Jeong Seong-Yeop5,Son Seok-Jun6,Kim Younghoon6,Shin Ok Sarah17

Affiliation:

1. Department of Biomedical Sciences, College of Medicine, Korea University, Seoul, Republic of Korea

2. Asian Pacific Influenza Institute, College of Medicine, Korea University, Seoul, Republic of Korea

3. Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA

4. Department of Medicine, Harvard Medical School, Boston, MA, USA

5. Microbial Institute for Fermentation Industry (MIFI), Sunchang-gun, Korea

6. BK21 Plus Graduate Program, Department of Animal Science and Institute Agricultural Science & Technology, Chonbuk National University, Jeonju, Korea

7. Department of Microbiology, College of Medicine, Korea University, Seoul, Republic of Korea

Abstract

Abstract In this study, we investigated antibacterial activities of 20 plant-derived natural compounds against Gram-negative enteric pathogens. We found that both flavonoids and non-flavonoids, including honokiol and magnolol, possess specific antibacterial activities against V. cholerae, but not against other species of Gram-negative bacterium which we tested. Using various antibacterial assays, we determined that there was a dose-dependent bactericidal and biofilm inhibitory activity of honokiol and magnolol against Vibrio cholerae. In addition to antibacterial activities, these molecules also induced an attenuating effect on reactive oxygen species (ROS) production and pro-inflammatory responses generated by macrophages in response to lipopolysaccharides (LPS). Additionally, Caenorhabditis elegans lethality assay revealed that honokiol and magnolol have an ability to extend a lifespan of V. cholerae-infected worms, contributing to prolonged survival of worms after lethal infection. Altogether, our data show for the first time that honokiol and magnolol may be considered as attractive protective or preventive food adjuncts for cholera.

Funder

Korean Health Technology R&D Projects

Ministry for Health & Welfare, Republic of Korea (O.S.S), and by the Cooperative Research Program for Agriculture Science & Technology Development

Rural Development Administration, Republic of Korea (S.Y.J.)

Publisher

Oxford University Press (OUP)

Subject

Organic Chemistry,Molecular Biology,Applied Microbiology and Biotechnology,General Medicine,Biochemistry,Analytical Chemistry,Biotechnology

Reference38 articles.

1. Cholera;Harris;Lancet,2012

2. Emergence of multidrug-resistant strain of Vibrio cholerae O1 in Bangladesh and reversal of their susceptibility to tetracycline after two years;Faruque;J Health Popul Nutr,2007

3. Single-dose azithromycin for the treatment of cholera in adults;Saha;N Engl J Med,2006

4. Baicalin, an emerging multi-therapeutic agent: pharmacodynamics, pharmacokinetics, and considerations from drug development perspectives;Srinivas;Xenobiotica,2010

5. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo;Bai;J. Biol. Chem,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3